Who is the host of DCAT Value Chain Insights’ Production to Prescription?

DCAT Value Chain Insights’ Production to Prescription is hosted by DCAT. The show is categorised under business (science) and has published 61 episodes.

How many episodes does DCAT Value Chain Insights’ Production to Prescription have?

DCAT Value Chain Insights’ Production to Prescription has published 61 episodes.

What topics does DCAT Value Chain Insights’ Production to Prescription cover?

DCAT Value Chain Insights’ Production to Prescription regularly covers business, science. It sits in the business category, with a science focus.

Is it hard to get booked on DCAT Value Chain Insights’ Production to Prescription?

DCAT Value Chain Insights’ Production to Prescription is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is DCAT Value Chain Insights’ Production to Prescription currently accepting guest pitches?

DCAT Value Chain Insights’ Production to Prescription hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

business

DCAT Value Chain Insights’ Production to Prescription

Q: How do I pitch DCAT Value Chain Insights’ Production to Prescription as a podcast guest?

DCAT Value Chain Insights’ Production to Prescription has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.

Q: How long are DCAT Value Chain Insights’ Production to Prescription episodes?

Episodes of DCAT Value Chain Insights’ Production to Prescription average 25 minutes. a focused format where a clear narrative arc and tight preparation matter most.

Q: What guest credentials does DCAT Value Chain Insights’ Production to Prescription typically look for?

Our data rates DCAT Value Chain Insights’ Production to Prescription's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

Hosted by DCAT · business · EN-US · 61 episodes

Audience: 4

Apple Podcasts Website

About this Podcast:

DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.

Pitch Analysis

Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Verified email

Booking probability

33%

Guest openness

Selective

Verified email on file

80/100

Required Score

Signup to Generate a Pitch

What is DCAT Value Chain Insights’ Production to Prescription?

DCAT Value Chain Insights’ Production to Prescription is a business podcast hosted by DCAT, with 61 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

About the host

DCAT hosts DCAT Value Chain Insights’ Production to Prescription, a business show with 61 episodes published.

Verified host email: ████████@████.comSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

DCAT Value Chain Insights’ Production to Prescription
Beyond ADCs: The Market for Next-Generation Conjugates
Sep 3, 202618 min
Next-generation complex conjugates, such as peptide conjugates, radioconjugates, ligand-conjugated antisense medicines, and small-molecule drug conjugates, are expected to outpace growth comparative antibody drug conjugates (ADCs), which are still slated for strong growth. Gaurav Chaudhary, CEO, Roots Analysis, a business intelligence firm serving the bio/pharmaceutical industry, provides the latest market analysis of these next-generation complex conjugates and ADCS. Support the show
Listen Show Notes
DCAT Value Chain Insights’ Production to Prescription
New Excipient Products: Are They Coming?
Aug 13, 202632 min
Support the show
Listen Show Notes
DCAT Value Chain Insights’ Production to Prescription
Pipeline Potential: Small-Molecule Drugs
Jul 9, 202620 min
New drug classes–proteolysis-targeting chimeras (PROTACs) and molecular glue degraders–are potentially a new source of product innovation for small-molecule drugs in their ability to reach previously “undruggable” drug targets. There have been several large deals among the bio/pharma majors and smaller innovator companies, with one drug candidate recently gaining FDA approval. What is the market potential and both the promise and limitations of these drug classes? Matthew Arnold, Principal Analyst and Content Strategist, Clarivate, provides the latest insights. Support the show
Listen Show Notes
DCAT Value Chain Insights’ Production to Prescription
CDMO Outlook: Small Molecules—What Lies Ahead?
Jun 4, 202635 minS0
As the industry reaches the mid-point in 2026, how are CDMOs of small-molecule drugs faring? The larger scale CDMOs with late-phase and/or commercial-scale capabilities are faring well while smaller and mid-sized CDMOs specializing in early-stage development and clinical-scale capabilities are facing some headwinds from more challenging trends in biotech financing, but opportunities lie ahead. Brian Scanlan, Managing Partner, Freedom Bioscience Partners, a strategic advisory firm to CROs, CDMOs, and investors, provides the latest insights.Support the show
Listen Show Notes
DCAT Value Chain Insights’ Production to Prescription
A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis
May 14, 202624 minS0
Support the show
Listen Show Notes

Guest Appearances

Recent guests on DCAT Value Chain Insights’ Production to Prescription. Study who booked and why before you pitch.

Gaurav Chaudhary

Roots Analysis

Matthew Arnold

Clarivate

Brian Scanlan

Freedom Bioscience Partners

Dr. Ute Schleyer

Vetter

Advertisers on this show

Sponsor detection runs nightly. Check back soon.

Best industries to pitch DCAT Value Chain Insights’ Production to Prescription for

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

businessstrong

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.

Podcasts like DCAT Value Chain Insights’ Production to Prescription

All podcasts More business Top in US Top 100 by Booking Probability Booking Probability Index How scoring works How to get on podcasts

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

FAQs

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.

How do agency tiers work?

Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.

What is a talent profile?

A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

How do agency tiers work?

What is a talent profile?

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

DCAT Value Chain Insights’ Production to Prescription

About this Podcast:

Pitch Analysis

What is DCAT Value Chain Insights’ Production to Prescription?

About the host

Recent episodes

Beyond ADCs: The Market for Next-Generation Conjugates

New Excipient Products: Are They Coming?

Pipeline Potential: Small-Molecule Drugs

CDMO Outlook: Small Molecules—What Lies Ahead?

A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis

Guest Appearances

Gaurav Chaudhary

Matthew Arnold

Brian Scanlan

Dr. Ute Schleyer

Advertisers on this show

Best industries to pitch DCAT Value Chain Insights’ Production to Prescription for

Podcasts like DCAT Value Chain Insights’ Production to Prescription

Every question we get asked beforesomeone starts their trial.

DCAT Value Chain Insights’ Production to Prescription

About this Podcast:

Pitch Analysis

What is DCAT Value Chain Insights’ Production to Prescription?

About the host

Recent episodes

Beyond ADCs: The Market for Next-Generation Conjugates

New Excipient Products: Are They Coming?

Pipeline Potential: Small-Molecule Drugs

CDMO Outlook: Small Molecules—What Lies Ahead?

A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis

Guest Appearances

Gaurav Chaudhary

Matthew Arnold

Brian Scanlan

Dr. Ute Schleyer

Advertisers on this show

Best industries to pitch DCAT Value Chain Insights’ Production to Prescription for

Podcasts like DCAT Value Chain Insights’ Production to Prescription

Every question we get asked beforesomeone starts their trial.

Every question we get asked before
someone starts their trial.

Every question we get asked before
someone starts their trial.